nodes	percent_of_prediction	percent_of_DWPC	metapath
Quazepam—CYP2C19—chronic kidney failure	0.526	0.611	CbGaD
Quazepam—CYP3A4—chronic kidney failure	0.335	0.389	CbGaD
Quazepam—CYP2C9—cardial valve—chronic kidney failure	0.0103	0.233	CbGeAlD
Quazepam—GABRR3—nerve—chronic kidney failure	0.00579	0.132	CbGeAlD
Quazepam—GABRR2—nerve—chronic kidney failure	0.00502	0.114	CbGeAlD
Quazepam—GABRR1—nerve—chronic kidney failure	0.00483	0.11	CbGeAlD
Quazepam—CYP2C19—urine—chronic kidney failure	0.00285	0.0649	CbGeAlD
Quazepam—CYP2C9—urine—chronic kidney failure	0.00221	0.0503	CbGeAlD
Quazepam—CYP3A4—urine—chronic kidney failure	0.00169	0.0384	CbGeAlD
Quazepam—CYP2C19—blood plasma—chronic kidney failure	0.00149	0.0339	CbGeAlD
Quazepam—GABRP—urethra—chronic kidney failure	0.00122	0.0278	CbGeAlD
Quazepam—CYP2C9—blood plasma—chronic kidney failure	0.00115	0.0263	CbGeAlD
Quazepam—GABRE—urethra—chronic kidney failure	0.000934	0.0212	CbGeAlD
Quazepam—GABRA2—cortex of kidney—chronic kidney failure	0.000903	0.0205	CbGeAlD
Quazepam—Clotiazepam—CYP2C18—chronic kidney failure	0.000898	0.0926	CrCbGaD
Quazepam—CYP3A4—blood plasma—chronic kidney failure	0.00088	0.02	CbGeAlD
Quazepam—Flurazepam—SLC22A2—chronic kidney failure	0.000847	0.0873	CrCbGaD
Quazepam—GABRB3—gonad—chronic kidney failure	0.000723	0.0164	CbGeAlD
Quazepam—Clotiazepam—CYP2B6—chronic kidney failure	0.000666	0.0687	CrCbGaD
Quazepam—Flunitrazepam—CYP2B6—chronic kidney failure	0.000576	0.0594	CrCbGaD
Quazepam—CYP2C19—digestive system—chronic kidney failure	0.000572	0.013	CbGeAlD
Quazepam—CYP2C19—blood—chronic kidney failure	0.000545	0.0124	CbGeAlD
Quazepam—CYP2C9—cardiovascular system—chronic kidney failure	0.000534	0.0122	CbGeAlD
Quazepam—Diazepam—CYP2C18—chronic kidney failure	0.000495	0.051	CrCbGaD
Quazepam—CYP2C9—digestive system—chronic kidney failure	0.000444	0.0101	CbGeAlD
Quazepam—Temazepam—CYP2B6—chronic kidney failure	0.000442	0.0456	CrCbGaD
Quazepam—Midazolam—CYP2B6—chronic kidney failure	0.000429	0.0442	CrCbGaD
Quazepam—CYP2C9—blood—chronic kidney failure	0.000423	0.00962	CbGeAlD
Quazepam—CYP3A4—renal system—chronic kidney failure	0.000412	0.00939	CbGeAlD
Quazepam—Clotiazepam—CYP2C19—chronic kidney failure	0.000402	0.0415	CrCbGaD
Quazepam—CYP3A4—kidney—chronic kidney failure	0.000399	0.00907	CbGeAlD
Quazepam—Diazepam—CYP2B6—chronic kidney failure	0.000367	0.0379	CrCbGaD
Quazepam—Flunitrazepam—CYP2C19—chronic kidney failure	0.000348	0.0359	CrCbGaD
Quazepam—CYP3A4—digestive system—chronic kidney failure	0.000338	0.0077	CbGeAlD
Quazepam—CYP3A4—blood—chronic kidney failure	0.000322	0.00733	CbGeAlD
Quazepam—Adinazolam—CYP2C19—chronic kidney failure	0.00031	0.032	CrCbGaD
Quazepam—Clonazepam—CYP3A4—chronic kidney failure	0.000276	0.0284	CrCbGaD
Quazepam—Temazepam—CYP2C19—chronic kidney failure	0.000267	0.0275	CrCbGaD
Quazepam—Clotiazepam—CYP3A4—chronic kidney failure	0.000256	0.0264	CrCbGaD
Quazepam—Alprazolam—CYP3A4—chronic kidney failure	0.000242	0.0249	CrCbGaD
Quazepam—Diazepam—PTGS1—chronic kidney failure	0.000242	0.0249	CrCbGaD
Quazepam—Clonazepam—ALB—chronic kidney failure	0.00024	0.0248	CrCbGaD
Quazepam—Diazepam—CYP2C19—chronic kidney failure	0.000222	0.0229	CrCbGaD
Quazepam—Flunitrazepam—CYP3A4—chronic kidney failure	0.000221	0.0228	CrCbGaD
Quazepam—Estazolam—CYP3A4—chronic kidney failure	0.000207	0.0213	CrCbGaD
Quazepam—Adinazolam—CYP3A4—chronic kidney failure	0.000197	0.0203	CrCbGaD
Quazepam—Prazepam—CYP3A4—chronic kidney failure	0.00019	0.0196	CrCbGaD
Quazepam—Flurazepam—CYP3A4—chronic kidney failure	0.000178	0.0183	CrCbGaD
Quazepam—Triazolam—CYP3A4—chronic kidney failure	0.000177	0.0183	CrCbGaD
Quazepam—Temazepam—CYP3A4—chronic kidney failure	0.00017	0.0175	CrCbGaD
Quazepam—Midazolam—CYP3A4—chronic kidney failure	0.000165	0.017	CrCbGaD
Quazepam—Flurazepam—ABCB1—chronic kidney failure	0.000148	0.0153	CrCbGaD
Quazepam—Diazepam—CYP3A4—chronic kidney failure	0.000141	0.0146	CrCbGaD
Quazepam—Midazolam—ABCB1—chronic kidney failure	0.000137	0.0141	CrCbGaD
Quazepam—Diazepam—ALB—chronic kidney failure	0.000123	0.0127	CrCbGaD
Quazepam—Diazepam—ABCB1—chronic kidney failure	0.000117	0.0121	CrCbGaD
Quazepam—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—chronic kidney failure	8.95e-05	0.00105	CbGpPWpGaD
Quazepam—CYP2C19—Biological oxidations—PTGS1—chronic kidney failure	8.79e-05	0.00103	CbGpPWpGaD
Quazepam—CYP2C9—Biological oxidations—CYP2C19—chronic kidney failure	8.77e-05	0.00103	CbGpPWpGaD
Quazepam—CYP2C9—Metapathway biotransformation—CYP2C19—chronic kidney failure	8.65e-05	0.00102	CbGpPWpGaD
Quazepam—GABRA1—Transmembrane transport of small molecules—ABCC3—chronic kidney failure	8.6e-05	0.00101	CbGpPWpGaD
Quazepam—GABRA1—Transmembrane transport of small molecules—GCKR—chronic kidney failure	8.6e-05	0.00101	CbGpPWpGaD
Quazepam—GABRR1—Transmembrane transport of small molecules—AVP—chronic kidney failure	8.55e-05	0.001	CbGpPWpGaD
Quazepam—GABRR1—Transmembrane transport of small molecules—ABCB1—chronic kidney failure	8.28e-05	0.000973	CbGpPWpGaD
Quazepam—CYP2C9—Arachidonic acid metabolism—PTGS2—chronic kidney failure	8.26e-05	0.00097	CbGpPWpGaD
Quazepam—GABRA1—Transmembrane transport of small molecules—ABCC2—chronic kidney failure	8.24e-05	0.000969	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—FABP1—chronic kidney failure	8.16e-05	0.000959	CbGpPWpGaD
Quazepam—GABRR2—Transmembrane transport of small molecules—AVP—chronic kidney failure	8.15e-05	0.000958	CbGpPWpGaD
Quazepam—CYP3A4—Biological oxidations—CYP2B6—chronic kidney failure	8.05e-05	0.000946	CbGpPWpGaD
Quazepam—CYP2C9—Biological oxidations—PTGS1—chronic kidney failure	8.02e-05	0.000942	CbGpPWpGaD
Quazepam—CYP2C19—Phase 1 - Functionalization of compounds—POMC—chronic kidney failure	7.95e-05	0.000935	CbGpPWpGaD
Quazepam—CYP3A4—Metapathway biotransformation—CYP2B6—chronic kidney failure	7.94e-05	0.000933	CbGpPWpGaD
Quazepam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic kidney failure	7.91e-05	0.00093	CbGpPWpGaD
Quazepam—GABRR2—Transmembrane transport of small molecules—ABCB1—chronic kidney failure	7.9e-05	0.000928	CbGpPWpGaD
Quazepam—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic kidney failure	7.81e-05	0.000918	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—ACAT1—chronic kidney failure	7.76e-05	0.000912	CbGpPWpGaD
Quazepam—GABRB3—BDNF signaling pathway—NFKB1—chronic kidney failure	7.64e-05	0.000898	CbGpPWpGaD
Quazepam—CYP2C19—Biological oxidations—CYP3A4—chronic kidney failure	7.61e-05	0.000894	CbGpPWpGaD
Quazepam—CYP2C19—Metapathway biotransformation—CYP3A4—chronic kidney failure	7.5e-05	0.000882	CbGpPWpGaD
Quazepam—CYP2C9—Phase 1 - Functionalization of compounds—POMC—chronic kidney failure	7.25e-05	0.000852	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—ACAT1—chronic kidney failure	7.07e-05	0.000831	CbGpPWpGaD
Quazepam—CYP3A4—Biological oxidations—CYP2C18—chronic kidney failure	6.98e-05	0.00082	CbGpPWpGaD
Quazepam—GABRR1—Transmembrane transport of small molecules—PPARA—chronic kidney failure	6.97e-05	0.000819	CbGpPWpGaD
Quazepam—CYP2C9—Biological oxidations—CYP3A4—chronic kidney failure	6.94e-05	0.000815	CbGpPWpGaD
Quazepam—CYP3A4—Metapathway biotransformation—CYP2C18—chronic kidney failure	6.88e-05	0.000809	CbGpPWpGaD
Quazepam—CYP2C9—Metapathway biotransformation—CYP3A4—chronic kidney failure	6.84e-05	0.000804	CbGpPWpGaD
Quazepam—GABRG3—Transmembrane transport of small molecules—AVP—chronic kidney failure	6.71e-05	0.000789	CbGpPWpGaD
Quazepam—GABRR2—Transmembrane transport of small molecules—PPARA—chronic kidney failure	6.65e-05	0.000781	CbGpPWpGaD
Quazepam—GABRB1—Transmembrane transport of small molecules—AVP—chronic kidney failure	6.61e-05	0.000777	CbGpPWpGaD
Quazepam—GABRA1—SIDS Susceptibility Pathways—IL1B—chronic kidney failure	6.6e-05	0.000775	CbGpPWpGaD
Quazepam—GABRG3—Transmembrane transport of small molecules—ABCB1—chronic kidney failure	6.5e-05	0.000764	CbGpPWpGaD
Quazepam—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic kidney failure	6.42e-05	0.000754	CbGpPWpGaD
Quazepam—GABRB1—Transmembrane transport of small molecules—ABCB1—chronic kidney failure	6.4e-05	0.000753	CbGpPWpGaD
Quazepam—GABRA1—SIDS Susceptibility Pathways—NFKB1—chronic kidney failure	6.15e-05	0.000723	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—ABCG1—chronic kidney failure	6.13e-05	0.000721	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—PIP5K1B—chronic kidney failure	6e-05	0.000705	CbGpPWpGaD
Quazepam—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—chronic kidney failure	5.9e-05	0.000693	CbGpPWpGaD
Quazepam—CYP3A4—Biological oxidations—CYP2C19—chronic kidney failure	5.78e-05	0.00068	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—LCAT—chronic kidney failure	5.77e-05	0.000678	CbGpPWpGaD
Quazepam—CYP3A4—Metapathway biotransformation—CYP2C19—chronic kidney failure	5.7e-05	0.00067	CbGpPWpGaD
Quazepam—CYP2C19—Biological oxidations—CYP1A1—chronic kidney failure	5.67e-05	0.000666	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—ABCG1—chronic kidney failure	5.59e-05	0.000657	CbGpPWpGaD
Quazepam—CYP2C19—Metapathway biotransformation—CYP1A1—chronic kidney failure	5.59e-05	0.000657	CbGpPWpGaD
Quazepam—GABRA1—SIDS Susceptibility Pathways—VEGFA—chronic kidney failure	5.59e-05	0.000656	CbGpPWpGaD
Quazepam—GABRA5—Transmembrane transport of small molecules—AVP—chronic kidney failure	5.49e-05	0.000645	CbGpPWpGaD
Quazepam—GABRG3—Transmembrane transport of small molecules—PPARA—chronic kidney failure	5.47e-05	0.000643	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—PIP5K1B—chronic kidney failure	5.47e-05	0.000643	CbGpPWpGaD
Quazepam—GABRA3—Transmembrane transport of small molecules—AVP—chronic kidney failure	5.39e-05	0.000634	CbGpPWpGaD
Quazepam—GABRB1—Transmembrane transport of small molecules—PPARA—chronic kidney failure	5.39e-05	0.000634	CbGpPWpGaD
Quazepam—GABRA5—Transmembrane transport of small molecules—ABCB1—chronic kidney failure	5.32e-05	0.000625	CbGpPWpGaD
Quazepam—GABRA2—Transmembrane transport of small molecules—AVP—chronic kidney failure	5.3e-05	0.000623	CbGpPWpGaD
Quazepam—CYP3A4—Biological oxidations—PTGS1—chronic kidney failure	5.29e-05	0.000622	CbGpPWpGaD
Quazepam—GABRB3—Transmembrane transport of small molecules—AVP—chronic kidney failure	5.26e-05	0.000619	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—LCAT—chronic kidney failure	5.26e-05	0.000618	CbGpPWpGaD
Quazepam—GABRA3—Transmembrane transport of small molecules—ABCB1—chronic kidney failure	5.22e-05	0.000614	CbGpPWpGaD
Quazepam—GABRR1—Transmembrane transport of small molecules—ALB—chronic kidney failure	5.18e-05	0.000609	CbGpPWpGaD
Quazepam—GABRG2—Transmembrane transport of small molecules—AVP—chronic kidney failure	5.17e-05	0.000607	CbGpPWpGaD
Quazepam—CYP2C9—Biological oxidations—CYP1A1—chronic kidney failure	5.17e-05	0.000607	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—PRKAG2—chronic kidney failure	5.14e-05	0.000604	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—PRKD1—chronic kidney failure	5.14e-05	0.000604	CbGpPWpGaD
Quazepam—GABRA2—Transmembrane transport of small molecules—ABCB1—chronic kidney failure	5.13e-05	0.000603	CbGpPWpGaD
Quazepam—GABRB3—Transmembrane transport of small molecules—ABCB1—chronic kidney failure	5.1e-05	0.000599	CbGpPWpGaD
Quazepam—CYP2C9—Metapathway biotransformation—CYP1A1—chronic kidney failure	5.1e-05	0.000599	CbGpPWpGaD
Quazepam—GABRG2—Transmembrane transport of small molecules—ABCB1—chronic kidney failure	5.01e-05	0.000588	CbGpPWpGaD
Quazepam—GABRR2—Transmembrane transport of small molecules—ALB—chronic kidney failure	4.94e-05	0.000581	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—SREBF2—chronic kidney failure	4.81e-05	0.000566	CbGpPWpGaD
Quazepam—GABRA1—SIDS Susceptibility Pathways—TNF—chronic kidney failure	4.79e-05	0.000563	CbGpPWpGaD
Quazepam—CYP3A4—Phase 1 - Functionalization of compounds—POMC—chronic kidney failure	4.78e-05	0.000562	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—PRKD1—chronic kidney failure	4.69e-05	0.000551	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—PRKAG2—chronic kidney failure	4.69e-05	0.000551	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—ABCC3—chronic kidney failure	4.65e-05	0.000546	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—LPIN1—chronic kidney failure	4.55e-05	0.000535	CbGpPWpGaD
Quazepam—GABRA1—Transmembrane transport of small molecules—AVP—chronic kidney failure	4.52e-05	0.000531	CbGpPWpGaD
Quazepam—GABRA5—Transmembrane transport of small molecules—PPARA—chronic kidney failure	4.48e-05	0.000526	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—LRP2—chronic kidney failure	4.46e-05	0.000524	CbGpPWpGaD
Quazepam—GABRA3—Transmembrane transport of small molecules—PPARA—chronic kidney failure	4.39e-05	0.000516	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—SREBF2—chronic kidney failure	4.39e-05	0.000516	CbGpPWpGaD
Quazepam—GABRA1—Transmembrane transport of small molecules—ABCB1—chronic kidney failure	4.38e-05	0.000514	CbGpPWpGaD
Quazepam—GABRA2—Transmembrane transport of small molecules—PPARA—chronic kidney failure	4.32e-05	0.000508	CbGpPWpGaD
Quazepam—GABRB3—Transmembrane transport of small molecules—PPARA—chronic kidney failure	4.29e-05	0.000504	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—ABCC3—chronic kidney failure	4.24e-05	0.000498	CbGpPWpGaD
Quazepam—CYP2C19—Biological oxidations—POMC—chronic kidney failure	4.23e-05	0.000497	CbGpPWpGaD
Quazepam—GABRG2—Transmembrane transport of small molecules—PPARA—chronic kidney failure	4.21e-05	0.000495	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—LPIN1—chronic kidney failure	4.15e-05	0.000487	CbGpPWpGaD
Quazepam—GABRG3—Transmembrane transport of small molecules—ALB—chronic kidney failure	4.07e-05	0.000478	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—LRP2—chronic kidney failure	4.06e-05	0.000478	CbGpPWpGaD
Quazepam—GABRB1—Transmembrane transport of small molecules—ALB—chronic kidney failure	4.01e-05	0.000471	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—FABP1—chronic kidney failure	3.98e-05	0.000468	CbGpPWpGaD
Quazepam—GABRA1—SIDS Susceptibility Pathways—IL6—chronic kidney failure	3.86e-05	0.000454	CbGpPWpGaD
Quazepam—CYP2C9—Biological oxidations—POMC—chronic kidney failure	3.85e-05	0.000453	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—CPT1A—chronic kidney failure	3.79e-05	0.000445	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—AGXT—chronic kidney failure	3.78e-05	0.000444	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—GATM—chronic kidney failure	3.78e-05	0.000444	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—LIPC—chronic kidney failure	3.69e-05	0.000434	CbGpPWpGaD
Quazepam—GABRA1—Transmembrane transport of small molecules—PPARA—chronic kidney failure	3.68e-05	0.000433	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—FABP1—chronic kidney failure	3.63e-05	0.000427	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—ACAT1—chronic kidney failure	3.46e-05	0.000406	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—CPT1A—chronic kidney failure	3.45e-05	0.000406	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—AGXT—chronic kidney failure	3.44e-05	0.000405	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—GATM—chronic kidney failure	3.44e-05	0.000405	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—chronic kidney failure	3.41e-05	0.000401	CbGpPWpGaD
Quazepam—CYP3A4—Biological oxidations—CYP1A1—chronic kidney failure	3.41e-05	0.000401	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—chronic kidney failure	3.38e-05	0.000397	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—chronic kidney failure	3.37e-05	0.000396	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—CYP2C19—chronic kidney failure	3.37e-05	0.000396	CbGpPWpGaD
Quazepam—CYP3A4—Metapathway biotransformation—CYP1A1—chronic kidney failure	3.36e-05	0.000395	CbGpPWpGaD
Quazepam—GABRA5—Transmembrane transport of small molecules—ALB—chronic kidney failure	3.33e-05	0.000391	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—SREBF1—chronic kidney failure	3.31e-05	0.000389	CbGpPWpGaD
Quazepam—GABRA3—Transmembrane transport of small molecules—ALB—chronic kidney failure	3.27e-05	0.000384	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—HMGCR—chronic kidney failure	3.22e-05	0.000379	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—MLXIPL—chronic kidney failure	3.21e-05	0.000378	CbGpPWpGaD
Quazepam—GABRA2—Transmembrane transport of small molecules—ALB—chronic kidney failure	3.21e-05	0.000377	CbGpPWpGaD
Quazepam—GABRB3—Transmembrane transport of small molecules—ALB—chronic kidney failure	3.19e-05	0.000375	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—FASN—chronic kidney failure	3.15e-05	0.000371	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—ACAT1—chronic kidney failure	3.15e-05	0.00037	CbGpPWpGaD
Quazepam—GABRG2—Transmembrane transport of small molecules—ALB—chronic kidney failure	3.13e-05	0.000368	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—chronic kidney failure	3.11e-05	0.000366	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—chronic kidney failure	3.08e-05	0.000362	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—SREBF1—chronic kidney failure	3.02e-05	0.000355	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—SLC22A2—chronic kidney failure	2.94e-05	0.000345	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—chronic kidney failure	2.94e-05	0.000345	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—MLXIPL—chronic kidney failure	2.93e-05	0.000344	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—FASN—chronic kidney failure	2.87e-05	0.000338	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—chronic kidney failure	2.87e-05	0.000337	CbGpPWpGaD
Quazepam—GABRA1—Transmembrane transport of small molecules—ALB—chronic kidney failure	2.74e-05	0.000322	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—ABCG1—chronic kidney failure	2.73e-05	0.000321	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—SLC22A2—chronic kidney failure	2.68e-05	0.000315	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—PIP5K1B—chronic kidney failure	2.67e-05	0.000314	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—ARG2—chronic kidney failure	2.62e-05	0.000308	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—chronic kidney failure	2.62e-05	0.000308	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—LCAT—chronic kidney failure	2.57e-05	0.000302	CbGpPWpGaD
Quazepam—CYP3A4—Biological oxidations—POMC—chronic kidney failure	2.54e-05	0.000299	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—ABCG1—chronic kidney failure	2.49e-05	0.000293	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—PIP5K1B—chronic kidney failure	2.44e-05	0.000286	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—FABP1—chronic kidney failure	2.4e-05	0.000282	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—ARG2—chronic kidney failure	2.39e-05	0.000281	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—DDC—chronic kidney failure	2.36e-05	0.000277	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—LCAT—chronic kidney failure	2.34e-05	0.000275	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—PRKAG2—chronic kidney failure	2.29e-05	0.000269	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—CYP2B6—chronic kidney failure	2.29e-05	0.000269	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—PRKD1—chronic kidney failure	2.29e-05	0.000269	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—AGXT—chronic kidney failure	2.27e-05	0.000267	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—GATM—chronic kidney failure	2.27e-05	0.000267	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—LPL—chronic kidney failure	2.25e-05	0.000265	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic kidney failure	2.18e-05	0.000256	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—DDC—chronic kidney failure	2.15e-05	0.000253	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—SREBF2—chronic kidney failure	2.14e-05	0.000252	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—CYP2B6—chronic kidney failure	2.09e-05	0.000245	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—PRKD1—chronic kidney failure	2.09e-05	0.000245	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—PRKAG2—chronic kidney failure	2.09e-05	0.000245	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—ACAT1—chronic kidney failure	2.08e-05	0.000244	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—GCKR—chronic kidney failure	2.07e-05	0.000243	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—ABCC3—chronic kidney failure	2.07e-05	0.000243	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—LPL—chronic kidney failure	2.05e-05	0.000241	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—LPIN1—chronic kidney failure	2.03e-05	0.000238	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—chronic kidney failure	1.99e-05	0.000234	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—LRP2—chronic kidney failure	1.98e-05	0.000233	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—CYP2C18—chronic kidney failure	1.98e-05	0.000233	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic kidney failure	1.98e-05	0.000233	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—SREBF2—chronic kidney failure	1.95e-05	0.00023	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—MLXIPL—chronic kidney failure	1.93e-05	0.000227	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—ABCC3—chronic kidney failure	1.89e-05	0.000222	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—GCKR—chronic kidney failure	1.89e-05	0.000222	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—LPIN1—chronic kidney failure	1.85e-05	0.000217	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—chronic kidney failure	1.81e-05	0.000213	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—LRP2—chronic kidney failure	1.81e-05	0.000213	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—CYP2C18—chronic kidney failure	1.81e-05	0.000213	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—SLC22A2—chronic kidney failure	1.77e-05	0.000208	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—CPT1A—chronic kidney failure	1.69e-05	0.000198	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—LIPC—chronic kidney failure	1.64e-05	0.000193	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—ABCG1—chronic kidney failure	1.64e-05	0.000193	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—POMC—chronic kidney failure	1.62e-05	0.000191	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—PIP5K1B—chronic kidney failure	1.61e-05	0.000189	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—ARG2—chronic kidney failure	1.57e-05	0.000185	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—LCAT—chronic kidney failure	1.54e-05	0.000181	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—CPT1A—chronic kidney failure	1.54e-05	0.000181	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—SCARB1—chronic kidney failure	1.52e-05	0.000179	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—PTGS1—chronic kidney failure	1.5e-05	0.000177	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—LIPC—chronic kidney failure	1.5e-05	0.000176	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—CYP2C19—chronic kidney failure	1.5e-05	0.000176	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—POMC—chronic kidney failure	1.48e-05	0.000174	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic kidney failure	1.48e-05	0.000174	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—SREBF1—chronic kidney failure	1.47e-05	0.000173	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—HMGCR—chronic kidney failure	1.43e-05	0.000169	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—DDC—chronic kidney failure	1.42e-05	0.000167	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—FASN—chronic kidney failure	1.4e-05	0.000165	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—SCARB1—chronic kidney failure	1.39e-05	0.000163	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—CYP2B6—chronic kidney failure	1.38e-05	0.000162	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—PRKAG2—chronic kidney failure	1.38e-05	0.000162	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—PRKD1—chronic kidney failure	1.38e-05	0.000162	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—PTGS1—chronic kidney failure	1.37e-05	0.000161	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic kidney failure	1.35e-05	0.000159	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—SREBF1—chronic kidney failure	1.34e-05	0.000158	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—HMGCR—chronic kidney failure	1.31e-05	0.000154	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—CYP3A4—chronic kidney failure	1.3e-05	0.000153	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—chronic kidney failure	1.29e-05	0.000152	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—SREBF2—chronic kidney failure	1.29e-05	0.000151	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—FASN—chronic kidney failure	1.28e-05	0.00015	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—ABCA1—chronic kidney failure	1.28e-05	0.00015	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—ABCC3—chronic kidney failure	1.24e-05	0.000146	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—GCKR—chronic kidney failure	1.24e-05	0.000146	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—LPIN1—chronic kidney failure	1.22e-05	0.000143	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—LRP2—chronic kidney failure	1.19e-05	0.00014	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—CYP2C18—chronic kidney failure	1.19e-05	0.00014	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—CYP3A4—chronic kidney failure	1.19e-05	0.000139	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—chronic kidney failure	1.18e-05	0.000139	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—ABCA1—chronic kidney failure	1.17e-05	0.000137	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—CAT—chronic kidney failure	1.08e-05	0.000127	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—ABCB1—chronic kidney failure	1.05e-05	0.000124	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—CPT1A—chronic kidney failure	1.01e-05	0.000119	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—LPL—chronic kidney failure	1e-05	0.000118	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—LIPC—chronic kidney failure	9.89e-06	0.000116	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—CYP2C19—chronic kidney failure	9.89e-06	0.000116	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—CAT—chronic kidney failure	9.87e-06	0.000116	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—CYP1A1—chronic kidney failure	9.69e-06	0.000114	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—ABCB1—chronic kidney failure	9.6e-06	0.000113	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—LPL—chronic kidney failure	9.15e-06	0.000108	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—SCARB1—chronic kidney failure	9.14e-06	0.000107	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—PTGS1—chronic kidney failure	9.04e-06	0.000106	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—MTHFR—chronic kidney failure	9.03e-06	0.000106	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—SREBF1—chronic kidney failure	8.87e-06	0.000104	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—PPARA—chronic kidney failure	8.86e-06	0.000104	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—CYP1A1—chronic kidney failure	8.84e-06	0.000104	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—HMGCR—chronic kidney failure	8.63e-06	0.000101	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—FASN—chronic kidney failure	8.44e-06	9.92e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—MTHFR—chronic kidney failure	8.24e-06	9.68e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—PPARA—chronic kidney failure	8.08e-06	9.5e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—ABCA1—chronic kidney failure	7.69e-06	9.04e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—POMC—chronic kidney failure	7.23e-06	8.49e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—POMC—chronic kidney failure	6.59e-06	7.74e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—ALB—chronic kidney failure	6.59e-06	7.74e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—CAT—chronic kidney failure	6.51e-06	7.65e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—ABCB1—chronic kidney failure	6.33e-06	7.44e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—NOS3—chronic kidney failure	6.3e-06	7.41e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—LPL—chronic kidney failure	6.03e-06	7.09e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—ALB—chronic kidney failure	6.01e-06	7.06e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—CYP1A1—chronic kidney failure	5.83e-06	6.85e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—PTGS2—chronic kidney failure	5.76e-06	6.77e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—NOS3—chronic kidney failure	5.75e-06	6.75e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—MTHFR—chronic kidney failure	5.43e-06	6.39e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—PPARA—chronic kidney failure	5.33e-06	6.26e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—PTGS2—chronic kidney failure	5.25e-06	6.18e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—POMC—chronic kidney failure	4.35e-06	5.11e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—ALB—chronic kidney failure	3.96e-06	4.66e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—NOS3—chronic kidney failure	3.79e-06	4.45e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—PTGS2—chronic kidney failure	3.47e-06	4.07e-05	CbGpPWpGaD
